Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types.

Park, Sojung; Lee, Sung Yong; Kim, Dojin; Sim, Yun Su; Ryu, Jeong-Seon; Choi, Juwhan; Lee, Su Hwan; Ryu, Yon Ju; Lee, Jin Hwa; Chang, Jung Hyun

Park, Sojung; Lee, Sung Yong; Kim, Dojin; Sim, Yun Su; Ryu, Jeong-Seon; Choi, Juwhan; Lee, Su Hwan; Ryu, Yon Ju; Lee, Jin Hwa; Chang, Jung Hyun.

Afiliação

Park S; Division of Pulmonary and Critical Care Medicine, College of Medicine, Ewha Womans University, 1071 Anyangcheon-Ro, Yangcheon-gu, Seoul, 07985, Republic of Korea.
Lee SY; Division of Respiratory, Allergy and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.
Kim D; Division of Allergy and Respiratory Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Gyeonggi, Republic of Korea.
Sim YS; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Seoul, Republic of Korea.
Ryu JS; Department of Internal Medicine, Inha University College of Medicine, Incheon, Republic of Korea.
Choi J; Division of Respiratory, Allergy and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.
Lee SH; Division of Pulmonary and Critical Care Medicine, College of Medicine, Ewha Womans University, 1071 Anyangcheon-Ro, Yangcheon-gu, Seoul, 07985, Republic of Korea.
Ryu YJ; Division of Pulmonary and Critical Care Medicine, College of Medicine, Ewha Womans University, 1071 Anyangcheon-Ro, Yangcheon-gu, Seoul, 07985, Republic of Korea.
Lee JH; Division of Pulmonary and Critical Care Medicine, College of Medicine, Ewha Womans University, 1071 Anyangcheon-Ro, Yangcheon-gu, Seoul, 07985, Republic of Korea.
Chang JH; Division of Pulmonary and Critical Care Medicine, College of Medicine, Ewha Womans University, 1071 Anyangcheon-Ro, Yangcheon-gu, Seoul, 07985, Republic of Korea. hs1017@ewha.ac.kr.

BMC Cancer ; 21(1): 52, 2021 Jan 11.

Article em En | MEDLINE | ID: mdl-33430803

Assuntos

Adenocarcinoma de Pulmão/tratamento farmacológico; Biomarcadores Tumorais/genética; Carcinoma Pulmonar de Células não Pequenas/tratamento farmacológico; Neoplasias Pulmonares/tratamento farmacológico; Mutação; Inibidores de Proteínas Quinases/uso terapêutico; Adenocarcinoma de Pulmão/genética; Adenocarcinoma de Pulmão/patologia; Idoso; Carcinoma Pulmonar de Células não Pequenas/genética; Carcinoma Pulmonar de Células não Pequenas/patologia; Receptores ErbB/genética; Feminino; Seguimentos; Humanos; Neoplasias Pulmonares/genética; Neoplasias Pulmonares/patologia; Masculino; Prognóstico; Estudos Retrospectivos; Taxa de Sobrevida

Palavras-chave

Adenocarcinoma; Epidermal growth factor receptor; Non-small cell lung cancer; Survival; Tyrosine kinase inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Adenocarcinoma de Pulmão / Neoplasias Pulmonares / Mutação Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google